422
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis of novel thiosemicarbazone derivatives as antidiabetic agent with enzyme kinetic studies and antioxidant activity

ORCID Icon, , , &
Pages 1284-1294 | Received 04 Apr 2022, Accepted 06 Jul 2022, Published online: 19 Jul 2022
 

Abstract

Novel thiosemicarbazone derivatives were synthesized via condensation reactions between the corresponding thiosemicarbazides and 4-(methylsulfonyl)acetophenone. The chemical structures of all compounds were elucidated by infrared (IR), 1H-NMR and 13C-NMR spectroscopy and mass spectrometry. Antioxidant studies of all compounds were performed by using CUPRAC, FRAP, DPPH methods. 2-{1-[4-(Methylsulfonyl)phenyl]ethylidene}-N-phenylhydrazinecarbothioamide (1) possessed good antioxidant activity with an SC50 value of 15.70 µM which also is higher than standard drug, ascorbic acid. All compounds were evaluated for their antidiabetic properties as α-glycosidase and α-amylase inhibitors. Compound 1 was found to be the most active compound against α-glucosidase and α-amylase with IC50 values of 1.58 µM and 3.24 µM, respectively. The enzyme kinetic studies demonstrated that compound 1 has a competitive mode of binding. Furthermore, molecular docking studies have elucidated the binding mechanism at the molecular level by examining the molecular interactions between compound 1 and these enzymes.

Graphical Abstract

Acknowledgments

The numerical calculations reported in this abstract were performed at The Scientific and Technological Research Council of Turkey (TUBITAK) ULAKBIM High Performance and Grid Computing Center (TRUBA resources).

Disclosure statement

The authors declare that they have no confict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.